Together with recent data suggesting increased serum CCL2 levels and deregulated CCR2+ blood monocytes responses in PD patients [39, 40], it remains possible that brain infiltrating monocytes are relevant for human disease, despite our negative results from the acute mouse model. The gene discussed is CCL2; the disease is Parkinson disease.